NASA To Test Supersonic Saucer-Shaped Vehicle

Tue, May 20, 2014

NASA plans to test its Low-Density Supersonic Decelerator (LDSD) experiment next month at the U.S. Navy's Pacific Missile Range Facility (PMRF) on Kauai, Hawaii.

The LDSD test is designed to investigate breakthrough technologies that will benefit landing future human and robotic Mars missions, as well as aid in safely returning large payloads to Earth. The NASA LDSD test over the Pacific Ocean will simulate the entry, descent and landing speeds a spacecraft would be exposed to when flying through the Martian atmosphere. During the test a large saucer-shaped disk carrying an inflatable inner tube-shaped decelerator and parachute system will be carried to an altitude of 120,000 feet by a giant balloon. After release from the balloon, rockets will lift the disk to 180,000 feet while reaching supersonic speeds. Traveling at 3.5 times the speed of sound, the saucer's decelerator will inflate, slowing the vehicle down, and then a parachute will deploy to carry it to the ocean's surface.

NASA has six potential dates for launch of the high altitude balloon carrying the LDSD experiment: June 3, 5, 7, 9, 11 and 13. The launch window for each date extends from 0700 to 0830 local time.

NASA's LDSD carries several onboard cameras. It is expected that video of selected portions of the test, including the rocket-powered ascent, will be downlinked and streamed live to several NASA websites.

NASA's LDSD program is part of the agency's Space Technology Mission Directorate, which is innovating, developing, testing and flying hardware for use in NASA's future missions.

(Image provided by NASA)

Read more:

NASA To Test Supersonic Saucer-Shaped Vehicle

Making Nanotechnology More Practical For Industrial-scale Manufacturing

May 20, 2014

Image Credit: National Science Foundation

[ Watch The Video: The Assembly Line Of The Future ]

National Science Foundation

NSFs Center for Hierarchical Manufacturing proves good test bed for large-scale nanomanufacturing designs Theres no shortage of ideas about how to use nanotechnology, but one of the major hurdles is how to manufacture some of the new products on a large scale. With support from the National Science Foundation (NSF), University of Massachusetts (UMass) Amherst chemical engineer Jim Watkins and his team are working to make nanotechnology more practical for industrial-scale manufacturing.

One of the projects theyre working on at the NSF Center for Hierarchical Manufacturing (CHM) is a roll-to-roll process for nanotechnology that is similar to what is used in traditional manufacturing. Theyre also designing a process to manufacture printable coatings that improve the way solar panels absorb and direct light. Theyre even investigating the use of self-assembling nanoscale products that could have applications for many industries.

New nanotechnologies cant impact the U.S. economy until practical methods are available for producing products, using them in high volumes, at low cost. CHM is researching the fundamental scientific and engineering barriers that impede such commercialization, and innovating new technologies to surmount those barriers, notes Bruce Kramer, senior advisor in the NSF Engineering Directorates Division of Civil, Mechanical and Manufacturing Innovation (CMMI), which funded the research.

The NSF Center for Hierarchical Manufacturing is developing platform technologies for the economical manufacture of next generation devices and systems for applications in computing, electronics, energy conversion, resource conservation and human health, explains Khershed Cooper, a CMMI program director.

The center creates fabrication tools that are enabling versatile and high-rate continuous processes for the manufacture of nanostructures that are systematically integrated into higher order structures using bottom-up and top-down techniques, Cooper says. For example, CHM is designing and building continuous, roll-to-roll nanofabrication systems that can print, in high-volume, 3-D nanostructures and multi-layer nanodevices at sub-100 nanometer resolution, and in the process, realize hybrid electronic-optical-mechanical nanosystems.

The research in this episode was supported by NSF award #1025020, Nanoscale Science and Engineering Centers (NSEC): Center for Hierarchical Manufacturing.

See the original post:

Making Nanotechnology More Practical For Industrial-scale Manufacturing

Check out the assembly line of the future (w/ Video)

9 hours ago by Miles O'brien Made to order, a phrase that began with the service industry, is now vital to manufacturing's future. Manufacturing production has recently grown at its fastest pace in more than a decade, creating more economic value per dollar spent than any other sector. Adding to this surge is customization--the ability to quickly and efficiently make what you want when you want it. Rapid, efficient customization is becoming a reality for high-tech engineers, students and "maker" enthusiasts. Credit: NBC Learn, U.S. Patent and Trademark Office, and National Science Foundation

There's no shortage of ideas about how to use nanotechnology, but one of the major hurdles is how to manufacture some of the new products on a large scale. With support from the National Science Foundation (NSF), University of Massachusetts (UMass) Amherst chemical engineer Jim Watkins and his team are working to make nanotechnology more practical for industrial-scale manufacturing.

One of the projects they're working on at the NSF Center for Hierarchical Manufacturing (CHM) is a roll-to-roll process for nanotechnology that is similar to what is used in traditional manufacturing. They're also designing a process to manufacture printable coatings that improve the way solar panels absorb and direct light. They're even investigating the use of self-assembling nanoscale products that could have applications for many industries.

"New nanotechnologies can't impact the U.S. economy until practical methods are available for producing products, using them in high volumes, at low cost. CHM is researching the fundamental scientific and engineering barriers that impede such commercialization, and innovating new technologies to surmount those barriers," notes Bruce Kramer, senior advisor in the NSF Engineering Directorate's Division of Civil, Mechanical and Manufacturing Innovation (CMMI), which funded the research.

"The NSF Center for Hierarchical Manufacturing is developing platform technologies for the economical manufacture of next generation devices and systems for applications in computing, electronics, energy conversion, resource conservation and human health," explains Khershed Cooper, a CMMI program director.

This video is not supported by your browser at this time.

"The center creates fabrication tools that are enabling versatile and high-rate continuous processes for the manufacture of nanostructures that are systematically integrated into higher order structures using bottom-up and top-down techniques," Cooper says. "For example, CHM is designing and building continuous, roll-to-roll nanofabrication systems that can print, in high-volume, 3-D nanostructures and multi-layer nanodevices at sub-100 nanometer resolution, and in the process, realize hybrid electronic-optical-mechanical nanosystems."

Explore further: Study: New nanomanufacturing processes needed

If the promise of nanotechnology is to be fulfilled, then research programs must leapfrog to new nanomanufacturing processes. That's the conclusion of a review of the current state of nanoscience and nanotechnology to be ...

Are you happy with your smartphone? Bill O'Neill, Professor of Laser Engineering and Director of the Institute for Manufacturing's Centre for Industrial Photonics isn't.

Read more:

Check out the assembly line of the future (w/ Video)

Home – MNE2013 London – 39th International Conference on …

MNE is a major annual international conference, devoted to micro and nano fabrication and manufacturing, held in a European country every September. The Conference brings together engineers and scientists from across the world to discuss recent progress and future trends in the fabrication, manufacturing, operation and application of micro and nano-structures and devices. Applications in electronics, photonics, electromechanics, environment and life sciences are also discussed.

MNE 2013 will be the 39th conference in a series that was started in Cambridge in 1975 and which was held most recently in Athens (2008), Ghent (2009), Genoa (2010), Berlin (2011) and Toulouse (2012). In September 2013 MNE will return to the UK after 10 years. The organising committee are pleased to announce that the conference will be held at Imperial College London. Judging on previous years, it is estimated that the conference will attract 500-800 participants.

London is for good reason a major destination for visitors. It has many internationally renowned museums and galleries, together with a history that stretches back to Roman times. There is a vibrant cultural scene that caters for all tastes. London has a large and diverse range of academic institutions, 4 of which appear in the Times Higher Education Supplements top 100 world universities. There is an extensive public transport system and the South Kensington area is linked directly to Heathrow via the Piccadilly Line of the Underground railway network. In September, the weather in London is pleasant, although there is always the possibility of rain.

The conference will open with the Welcome Reception, held on Monday 16 September starting at 7:00 PM.

The conference Registration Desk will be open from 7:00 PM on Monday, and from 8:00 AM onwards on Tuesday, Wednesday and Thursday.

The Technical Programme sessions will be held from Tuesday 17 September through to Thursday 19 September, with the meeting closing at the end of the afternoon. Oral presentations are organised in four parallel sessions, Tuesday to Thursday, starting at 8.30 AM. Posters can be set-up at the start of the conference, Monday, 16 September, from 7:00 PM, and can be left through the duration of the conference, until 3:40 PM on Thursday, 19 September. Posters are organised in two Poster Sessions, 4:50 PM 6:20 PM Tuesday 17 September, and 4:50 PM 6:20 PM, Wednesday 18 September.

The Exhibition opens at the Welcome Reception, and closes on Thursday, 19 September at 3:40 PM.

Lunch and tea/coffee will be provided at the conference.

The Conference Dinner takes placeon Wednesday the 18 September from 7:00 PM onwards at the Science Museum, London. The Museum is adjacent to Imperial College London.

View post:

Home - MNE2013 London - 39th International Conference on ...

Landmark Gift of $100 Million from the Marie-Josee and Henry R. Kravis Foundation Will Support Groundbreaking Approach …

Contact Information

Available for logged-in reporters only

Newswise Memorial Sloan Kettering Cancer Center (MSK) today launched an ambitious initiative to improve cancer care and research through genomic analysis. The new program will reshape clinical trials and speed the translation of novel molecular discoveries into routine clinical practice. The Marie-Jose and Henry R. Kravis Center for Molecular Oncology (CMO) is named in honor of Marie-Jose and Henry R. Kravis, whose transformative gift of $100 million will make it possible to realize the promise of precision oncology and support the development of new, individualized cancer therapies and diagnostic tools.

Progress in our understanding of the biology of cancer has completely shifted the way we think about and treat cancer, says Craig Thompson, MD, MSK President and CEO. Were moving away from the concept of treating cancer as many different types of the same disease and toward treating each persons cancer as its own unique disease. Now, thanks to the inspiring generosity of the Marie-Jose and Henry R. Kravis Foundation, we will be able to expand and intensify this effort, ushering in what will truly be a new era of precision medicine.

Throughout the course of my involvement at Memorial Sloan Kettering, I have been deeply impressed by the dedication, experience, and competence of the physicians and scientists who are working to unravel the complexities of cancer, says Marie-Jose Kravis, who has been a member of MSKs Boards of Overseers and Managers since October 2000 and is Chair of the Board of the Sloan Kettering Institute. Henry and I are delighted to support this exciting new initiative, which offers such hope to people around the world.

Memorial Sloan Kettering has already proven itself to be a leader in understanding cancer at the genetic level and in putting that knowledge to work for patients, says Henry R. Kravis. The new Center for Molecular Oncology will take these efforts to an entirely new level, and I look forward with great anticipation to the discoveries that lie ahead.

Archived tumor specimens and tissues obtained in clinical trials will be comprehensively profiled by next-generation sequencing and other molecular technologies. The molecular information of each tumor will then be correlated with clinical outcomes to better understand the significance of genetic alterations in tumors and the opportunities they offer for treating cancers more precisely.

The first application of the genomic revolution of the past decade is now being applied to cancer, says Jos Baselga, MD, Physician-in-Chief of Memorial Hospital. We have learned that cancer is actually a disease of the genome, and moving forward, we will need to integrate the vast amounts of molecular discoveries being made with clinical data to develop tumor-specific treatments. The CMO will be the first program in the country to span the full range of activities required to bridge these molecular insights into clinical innovations.

MSK with its exceptionally powerful and seamless integration of clinical and scientific teams focused on cancer is uniquely positioned to launch an initiative of the ambition and scope of the CMO. The aim is to analyze over 10,000 patient tumors in the CMOs first year alone, with an eye toward offering molecular analysis for every type of cancer and for all MSK patients.

In terms of structure, the Marie-Jose and Henry R. Kravis Center for Molecular Oncology epitomizes the multidisciplinary approach to cancer research, which demands that we fully link programs and departments institution-wide so that we can inform each others work with our best and brightest ideas, says Joan Massagu, PhD, Director of the Sloan Kettering Institute.

The rest is here:

Landmark Gift of $100 Million from the Marie-Josee and Henry R. Kravis Foundation Will Support Groundbreaking Approach ...

InSilico Medicine Opens Office at the Emerging Technology Centers (ETC) at Johns Hopkins University Eastern Campus

Baltimore, MD (PRWEB) May 20, 2014

InSilico Medicine, Inc, the aging and longevity bioinformatics and drug discovery company, today announced the opening of its office in Baltimore within the Emerging Technology Centers (ETC) at Johns Hopkins University Eastern Campus.

InSilico Medicine, Inc is a Baltimore-based bioinformatics and drug discovery company specializing in cancer, aging research and personalized medicine in age-related diseases. The company developed methods and software tools to predict the effectiveness of the various targeted drugs in oncology and extrapolated these methods to evaluate the possible geroprotective properties of the many drugs with known molecular targets. The mission of InSilico Medicine is to find working solutions to treat, cure and prevent age-related diseases and aging itself through excellence in knowledge management, machine learning and bioinformatics, relentless pursuit for new drug, omics and clinical outcomes data, development of reliable in silico drug screening methods, novel validation approaches and strong international partnerships in personalized medicine.

The state of the whole area of biomedical sciences today resembles that of the dawn of the personal computing in the 80s or Internet in the 90s. And as some of the discoveries transition from the laboratory into clinical practice and mainstream use, Baltimore may eclipse Silicon Valley. Baltimore is one of the few rapidly regenerating and developing cities with highly qualified labor and cost-effective infrastructure and we are proud to join this thriving community. ETC allows the innovative companies to develop within the Johns Hopkins ecosystem and move fast into the emerging areas of science and technology while absorbing the culture of excellence, said Alex Zhavoronkov, PhD, CEO of InSilico Medicine, Inc.

To participate in the rapidly growing science and technology hub in Baltimore and to take advantage of the innovation-friendly environment developed by the community of the top industry captains, InSilico Medicine selected the Emerging Technology Centers at Johns Hopkins Eastern Campus as the optimal location for its research and development operations. This location provides access to thousands of highly educated bioinformatics professionals and interns to work on the highly-ambitious high-impact projects.

We are extremely excited to welcome Insilico Medicine as an ETC portfolio company, said Deborah Tillett, ETCs President. Their amazing research in productive longevity promises to change the future for all of us; they are a great addition to ETC and the City, she concluded.

Proximity to the major academic institutions like the Johns Hopkins University, Johns Hopkins Medicine, National Institute on Aging and University of Maryland will allow us to hire the recent graduates and interns as well as collaborate with some of the worlds most advanced geneticists, bioinformaticians and computer scientists. We aim to be a driver of change in medicine embracing the concept of productive longevity and shifting the paradigms from treatment to personalized prevention. Our approach to evaluating the ability of drugs to slow down the age-related processes and possibly repair the accumulated damage is unique and we would be very proud if it becomes one of the many breakthroughs originating from this Mecca of biomedicine, said Qingsong Zhu, PhD, COO of InSilico Medicine, Inc.

Many things are aligned in Baltimore to propel innovative start-up companies in healthcare. Access to world-class researchers and talent in biomedicine, technology and healthcare here in Maryland is unparalleled. If you couple that intellectual asset with a growing entrepreneurial base, a robust investment community, and the active involvement of large prominent institutions like the Johns Hopkins University, Johns Hopkins Medicine, BioHealth Innovation, and Northrop Grumman, as seen in the recent successful launch of DreamIT Health Baltimore, Baltimores first health accelerator, you start to see the initial sparks to what will undoubtedly lead to an explosion of innovations. We already see those sparks developing rapidly and InSilico Medicine is a testament to the growing prominence of Baltimore for innovative international companies. Its aim of combating cancer and aging through the use of genomics and novel bioinformatics comes at a very exciting and opportune time, states Benjamin Seo, a Partner at emocha Mobile Health Inc. a company, spun-out of technology developed at Johns Hopkins, offering a mobile health platform for remote patient management on a global scale.

See the original post here:

InSilico Medicine Opens Office at the Emerging Technology Centers (ETC) at Johns Hopkins University Eastern Campus

Intro to Harriet Beinfield: Why should I try Chinese Medicine? – Video


Intro to Harriet Beinfield: Why should I try Chinese Medicine?
Efrem Korngold, LAc,OMD and Harriet Beinfield, LAc became two of the first non-Asian acupuncturists in North America in 1973. Chinese Medicine Works is their San Francisco acupuncture clinic...

By: ChineseMedicineWorks

Go here to read the rest:

Intro to Harriet Beinfield: Why should I try Chinese Medicine? - Video

Reco Chapple: Designing Kandi Burruss’ Wedding Gown & Feuding w/ Married 2 Medicine’s Mariah Huq (2) – Video


Reco Chapple: Designing Kandi Burruss #39; Wedding Gown Feuding w/ Married 2 Medicine #39;s Mariah Huq (2)
[EXCLUSIVE] In an exclusive with theJasmineBRAND.com, fashion designer Reco Chapple talks about designing Kandi Burruss #39; wedding gown, feuding With #39;Married to Medicine #39;s #39; Mariah Huq and more....

By: thejasminebrand

More here:

Reco Chapple: Designing Kandi Burruss' Wedding Gown & Feuding w/ Married 2 Medicine's Mariah Huq (2) - Video

Married To Medicine After Show Season 2 Episode 7 "A Fashion Faux Pas" | AfterBuzz TV – Video


Married To Medicine After Show Season 2 Episode 7 "A Fashion Faux Pas" | AfterBuzz TV
AFTERBUZZ TV -- Married To Medicine edition, is a weekly "after show" for fans of Bravo #39;s Married To Medicine. In this show, host English Cleveland breaks down the episode in which Dr. Simone...

By: AfterBuzz TV

See the original post:

Married To Medicine After Show Season 2 Episode 7 "A Fashion Faux Pas" | AfterBuzz TV - Video

"In Your Genes" – Swedish Cancer Institute Personalized Medicine – Video


"In Your Genes" - Swedish Cancer Institute Personalized Medicine
http://SwedishCancerInstitute.org The Swedish Cancer Institute has a new weapon in the search for a cure. It #39;s personalized medicine, where DNA sequencing of a patient #39;s cancer cells helps...

By: swedishseattle

Read more here:

"In Your Genes" - Swedish Cancer Institute Personalized Medicine - Video

Precision for Medicine Meeting the Clinical Utility Needs Webinar – Video


Precision for Medicine Meeting the Clinical Utility Needs Webinar
Increasingly the FDA and payers are requesting clinical utility evidence as part of their approval and coverage processes for both CDx and IVDs. Precision will explore the implications of factors...

By: Precision for Medicine

View post:

Precision for Medicine Meeting the Clinical Utility Needs Webinar - Video